Skip to content

VEVPPDFP-Each

Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free

VEVPPDFP-Each Bard StatLockPICC Plus Stabilization Device is a sterile, latex-free medical tool with fixed posts and foam anchor pad, priced at $13.95. Ideal for securing PICC lines in adult patients, it reduces movement, irritation, and infection risk during long-term IV therapy.

$13.95 $23.23-40%

● In stock

Buy at Diabetesstore.com →

Price and availability may change. Click to see current details on Diabetesstore.com.

Key features

  • Sterile packaging for safe use
  • Latex-free to prevent allergic reactions
  • Foam anchor pad for secure adhesion
  • Fixed posts for stable catheter hold
  • Adult-sized for proper fit
  • Crescent shape for comfort
  • Single-use for infection control

Pros

  • +Secure hold reduces line movement
  • +Latex-free for sensitive skin
  • +Sterile and ready to use
  • +Comfortable crescent design
  • +Supports infection prevention
!

Cons

  • Fixed posts not adjustable
  • Single-use increases supply needs
  • May require precise placement

About VEVPPDFP-Each Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free

What is VEVPPDFP-Each Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free?

The VEVPPDFP-Each Bard StatLockPICC Plus Stabilization Device is a medical-grade solution designed to securely anchor peripherally inserted central catheters (PICC) in adult patients. Featuring a foam anchor pad and fixed posts, this sterile, latex-free device helps minimize catheter movement, reducing the risk of irritation, dislodgement, and infection. It's engineered for reliable performance during extended IV therapy, offering clinicians and caregivers a trusted method for catheter stabilization in home care or clinical settings.

Key features

  • Sterile Packaging — Ensures safe, ready-to-use application in clinical environments.
  • Latex-Free Construction — Reduces allergy risk for sensitive patients.
  • Foam Anchor Pad — Provides cushioned, secure adhesion to the skin.
  • Fixed Posts — Hold PICC lines firmly in place without slippage.
  • Adult Size — Designed for optimal fit on adult patients.
  • Crescent Design — Enhances comfort and conforms to body contours.
  • Single-Use Device — Promotes infection control and hygiene.

Who is VEVPPDFP-Each Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free for?

This stabilization device is intended for healthcare providers, home care nurses, and patients managing long-term IV therapy. It’s especially beneficial for individuals with PICC lines requiring consistent, secure anchoring to prevent complications. Suitable for use in hospitals, outpatient centers, and home settings, it supports safe and effective vascular access management.

How does VEVPPDFP-Each Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free compare?

Compared to standard adhesive tapes or generic anchor pads, the StatLockPICC Plus offers superior mechanical stability with its fixed post system, reducing reliance on adhesives alone. Unlike reusable or adjustable models, this fixed-post version ensures consistent positioning and minimizes manipulation risk. It outperforms basic foam pads in retention and safety, particularly in active or high-mobility patients, while maintaining skin integrity better than tape-only methods.

🎯

Best use cases

  • Securing PICC lines in adults
  • Long-term IV therapy at home
  • Hospital-based catheter care
  • Preventing catheter dislodgement
  • Reducing skin irritation from tape
🛒

Is Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free right for you?

This device is best for healthcare providers or caregivers managing adult patients with PICC lines. No advanced skills required—just basic catheter care knowledge. Ideal for home health, hospitals, or outpatient use. Consider alternatives like adjustable anchor devices if flexibility in positioning is needed, or adhesive-only systems for short-term use. Always verify compatibility with existing catheter types.

How it compares: Compared to adhesive tapes or generic pads, this device offers stronger mechanical fixation. It outperforms standard foam pads in stability and safety, especially for active patients, while providing better skin protection than tape-only methods.

More from Diabetesstore.com

?

Frequently Asked Questions

What is the VEVPPDFP-Each Bard StatLockPICC Plus used for?

It stabilizes PICC lines in adult patients, preventing movement, dislodgement, and skin irritation during IV therapy. The fixed posts and foam pad ensure secure, comfortable anchoring.

Does the device contain latex?

No, the VEVPPDFP-Each Bard StatLockPICC Plus is latex-free, making it safer for patients with latex allergies or sensitivities.

How do you apply the StatLockPICC Plus device?

Clean and dry the skin, position the foam pad near the insertion site, insert the catheter into the fixed posts, and press firmly to secure adhesion.

Is this device sterile?

Yes, each unit comes in sterile packaging, ensuring it's ready for safe, clinical use without additional disinfection.

Can this be reused?

No, it is designed for single-use only to maintain sterility and prevent infection risks during catheter stabilization.

How much does Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free cost?

Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free is $13.95 at Diabetesstore.com, marked down from $23.23 (save 40%). Prices may change — click through to Diabetesstore.com for the latest.

Is Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free in stock at Diabetesstore.com?

Yes, Bard StatLockPICC Plus Stabilization Device, Foam Anchor Pad, Fixed Posts, Sterile, Latex-Free is currently in stock at Diabetesstore.com.

Specifications

Brand
VEVPPDFP-Each
SKU
85167
Last updated May 14, 2026